Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 8, 2005, Pages 1385-1388

  Kawai, Yoshiko ^a   Taniuchi, Saburo ^a   Okahara, Shigeki ^a   Nakamura, Masuhisa ^a   Gemba, Munekazu ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cisplatin; Nedaplatin; Nephrotoxicity; Platinum accumulation

Indexed keywords

CISPLATIN; CREATININE; GLUCOSE; N ACETYL BETA GLUCOSAMINIDASE; NEDAPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG TISSUE LEVEL; GLUCOSURIA; INCIDENCE; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; RAT; TOXICITY TESTING; URINALYSIS; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CREATININE; GLYCOSURIA; KIDNEY; MALE; ORGANOPLATINUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 25644440569     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1385     Document Type: Article

References (28)

1. Rosenberg B., Adv. Exp. Med. Biol., 91, 129-150 (1977).
2. Lebwohl D., Canetta R., Eur. J. Cancer, 34, 1522-1534 (1998).
3. Takahara P. M., Rosenzweig A. C., Frederick C. A., Lippard S. J., Nature (London), 377, 649-652 (1995).
4. Hill J. M., Speer R. J., Anticancer Res., 2, 173-186 (1982).
5. Arany I., Safirstein R. L., Semin. Nephrol., 23, 460-464 (2003).
6. Dobyan D. C., Levi J., Jacobs C., Kosek J., Weiner M. W., J. Pharmacol. Exp. Ther., 213, 551-556 (1980).
7. Safirstein R., Winston J., Goldstein M., Moel D., Dikman S., Guttenplan J., Am. J. Kidney Dis., 8, 356-367 (1986).
8. Jacobs C., Kalman S. M., Trotton M., Cancer Treat. Rep., 64, 1223-1226 (1980).
9. Safirstein R., Miller P., Guttenplan J. B., Kidney Int., 25, 753-758 (1984).
10. Lehane D., Winston A., Gray R., Daskal Y., Int. J. Radiat. Oncol. Biol. Phys., 5, 1393-1399 (1979).
11. Madias N. E., Harrington J. T., Am. J. Med., 65, 307-314 (1978).
12. Desoize B., Madoulet C., Crit. Rev. Oncol. Hematol., 42, 317-325 (2002).
13. Totani T., Aono K., Adachi Y., Komura M., Shiratori O., Sato K., "Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy," ed. by Nicolini M., Martinus Nijhoff Publishing, Boston, 1988, pp. 744-748.
14. Shiratori O., Kanai H., Uchida N., Takeda Y., Totani T., Sato K., "Recent Advances in Chemotherapy," ed. by Ishigami J., University of Tokyo Press, Tokyo, 1985, pp. 635-636.
15. Alberts D. S., Fanta P. T., Running K. L., Adair L. P., Jr, Garcia D. J., Liu-Stevens R., Salmon S. E., Cancer Chemother. Pharmcol., 39, 493-497 (1997).
16. Majima H., "Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy," ed. by Howell S. B., NY Plenum, New York, 1991, pp. 345-355.
17. Uchida N., Takeda Y., Hojo K., Maekawa R., Sugita K., Yoshioka T., Eur. J. Cancer, 34, 1796-1801 (1998).
18. Kameyama Y., Okazaki N., Nakagawa M., Koshida H., Nakamura M., Gemba M., Toxicol Lett., 52, 15-24 (1990).
19. Cui Y., Sugimoto K., Kawai Y., Sudoh T., Gemba M., Fujimura A., Chronobiol. Int., 21, 601-611 (2004).
20. Hong W. S., Min Y. I., Kim H. T., Cho Y. B., Kim K. H., Kim D. K., J. Korean Med. Sci., 10, 269-274 (1995).
21. Matsumoto Y., Ishiko O., Nakagawa E., Sumi T., Hyun Y., Ando Y., Ogita S., Oncol. Rep., 8, 1269-1273 (2001).
22. Leibbrandt M. E. I., Wolfgang G. H. I., Toxicol. Appl. Pharmacol., 132, 245-252 (1995).
23. Devarajan P., Tarabishi R., Mishra J., Ma Q., Kourvetaris A., Vougiouka M., Boulikas T., Anticancer Res., 24, 2193-2200 (2004).
24. Ota K., Oguma T., Shimamura K., Anticancer Res., 14, 1383-1388 (1994).
25. Sasaki Y., Tamura T., Eguchi K., Shinkai T., Fujiwara Y., Fukuda M., Ohe Y., Bungo M., Horichi N., Niimi S., Minato K., Nakagawa K., Saijo N., Cancer Chemother. Pharmacol., 23, 243-246 (1989).
26. Endo T., Kimura O., Sakata M., Toxicology, 146, 187-195 (2000).
27. Ludwig T., Riethmuller C., Gekle M., Schwerdt G., Oberleithner H., Kidney Int., 66, 196-202 (2004).
28. Nakamura M., Koshida H., Miyata K., Yamamoto K., Muraoka Y., Clinical Rep., 29, 3585-3612 (1995).